Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.740
+0.058 (8.54%)
At close: Jan 21, 2025, 4:00 PM
0.743
+0.003 (0.41%)
After-hours: Jan 21, 2025, 7:59 PM EST
Cognition Therapeutics Stock Forecast
CGTX's stock price has decreased by -67.83% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for CGTX stock have an average target of 8.30, with a low estimate of 1.50 and a high estimate of 14. The average target predicts an increase of 1,021.62% from the current stock price of 0.74.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 19, 2024.
Analyst Ratings
The average analyst rating for CGTX stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 3 | 3 | 4 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 2 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 6 | 6 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B. Riley Securities | B. Riley Securities | Hold → Strong Buy Upgrades $1 → $1.5 | Hold → Strong Buy | Upgrades | $1 → $1.5 | +102.70% | Dec 19, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +1,386.49% | Dec 19, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $6 | Strong Buy | Maintains | $5 → $6 | +710.81% | Dec 19, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +575.68% | Nov 27, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +1,386.49% | Nov 15, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.87
from -0.86
EPS Next Year
-0.77
from -0.87
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | n/a | n/a | n/a | |||
Avg | n/a | n/a | n/a | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.65 | -0.33 | -0.48 | ||
Avg | -0.87 | -0.77 | -1.23 | ||
Low | -1.08 | -1.68 | -2.54 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.